Testing effectiveness (Phase 2)WithdrawnNCT05279859
What this trial is testing
Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies
Who this might be right for
Acute Myeloid Leukemia
Erasca, Inc.
Showing 20 of 3,929 results